Open Heart (Jun 2020)

Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV

  • Thor Trovik,
  • Juha Hartikainen,
  • Evald Høj Christiansen,
  • Niels Ramsing Holm,
  • Ole Fröbert,
  • Christian Juhl Terkelsen,
  • Michael Maeng,
  • Lisette Okkels Jensen,
  • Jens Aarøe,
  • Thomas Engstrøm,
  • Indulis Kumsars,
  • Matti Niemelä,
  • Andrejs Erglis,
  • Kari Kervinen,
  • Andis Dombrovskis,
  • Vytautas Abraitis,
  • Aleksandras Kibarskis,
  • Gustavs Latkovskis,
  • Dace Sondore,
  • Inga Narbute,
  • Markku Eskola,
  • Hannu Romppanen,
  • Mika Laine,
  • Mikko Pietila,
  • Pål Gunnes,
  • Lasse Hebsgaard,
  • Fredrik Calais,
  • Jan Ravkilde,
  • Terje K Steigen,
  • Leif Thuesen,
  • Jens F Lassen

DOI
https://doi.org/10.1136/openhrt-2018-000947
Journal volume & issue
Vol. 7, no. 1

Abstract

Read online

BackgroundIt is still uncertain whether coronary bifurcations with lesions involving a large side branch (SB) should be treated by stenting the main vessel and provisional stenting of the SB (simple) or by routine two-stent techniques (complex). We aimed to compare clinical outcome after treatment of lesions in large bifurcations by simple or complex stent implantation.MethodsThe study was a randomised, superiority trial. Enrolment required a SB≥2.75 mm, ≥50% diameter stenosis in both vessels, and allowed SB lesion length up to 15 mm. The primary endpoint was a composite of cardiac death, non-procedural myocardial infarction and target lesion revascularisation at 6 months. Two-year clinical follow-up was included in this primary reporting due to lower than expected event rates.ResultsA total of 450 patients were assigned to simple stenting (n=221) or complex stenting (n=229) in 14 Nordic and Baltic centres. Two-year follow-up was available in 218 (98.6%) and 228 (99.5%) patients, respectively. The primary endpoint of major adverse cardiac events (MACE) at 6 months was 5.5% vs 2.2% (risk differences 3.2%, 95% CI −0.2 to 6.8, p=0.07) and at 2 years 12.9% vs 8.4% (HR 0.63, 95% CI 0.35 to 1.13, p=0.12) after simple versus complex treatment. In the subgroup treated by newer generation drug-eluting stents, MACE was 12.0% vs 5.6% (HR 0.45, 95% CI 0.17 to 1.17, p=0.10) after simple versus complex treatment.ConclusionIn the treatment of bifurcation lesions involving a large SB with ostial stenosis, routine two-stent techniques did not improve outcome significantly compared with treatment by the simpler main vessel stenting technique after 2 years.Trial registration numberNCT01496638.